Alcidion Group

Alcidion Group Long-term Debt

The Long-Term Debt of Alcidion Group (ALC.AX) as of Nov 11, 2026 is 694,000.00 AUD. In the previous year, Long-Term Debt was 998,000.00 AUD — a change of -30.46% (lower).

Long-term Debt

694,000.00AUD

YoY

-30.46%

Last updated:

Long-Term Debt of Alcidion Group is 2025 694,000.00 AUD. Long-Term Debt of Alcidion Group was 2024 998,000.00 AUD. It decreases by -30.46% lower compared to the previous year.

The Alcidion Group Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2018
0.00 AUD
Jan 1, 2019
0.00 AUD
Jan 1, 2020
139,380.00 AUD
Jan 1, 2021
18,000.00 AUD
Jan 1, 2022
1.87 M AUD
Jan 1, 2023
1.46 M AUD
Jan 1, 2024
998,000.00 AUD
Jan 1, 2025
694,000.00 AUD
The Alcidion Group Long-term Debt history
YEARLong-term DebtYoY
694,000.00AUD-30.46%
998,000.00AUD-31.74%
1.46 MAUD-21.73%
1.87 MAUD+10,277.78%
18,000.00AUD-87.09%
139,380.00AUD—
0.00AUD—
0.00AUD—
0.00AUD-100.00%
1.50 MAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alcidion Group Stock analysis

What does Alcidion Group do? Alcidion Group Ltd. generates revenue through the development and licensing of its healthcare software products, including Miya Precision, Miya Observations, Flow, Task Management, and PAS, marketed under the Miya brand. The company also resells selected healthcare software from strategic partners and provides implementation, support, maintenance, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its flagship product Miya Precision, a FHIR-event platform-based solution, supports clinical and operational applications, while Smartpage offers hospital communication and task management via smartphone and web. The firm serves over 400 hospitals across its key markets. Miya Precision and its associated modules form the core of Alcidion's product portfolio, targeting hospitals seeking integrated clinical solutions. Smartpage, Patientrack, and Silverlink PCS complement these offerings, catering to diverse healthcare communication and operational needs. The company’s revenue streams are driven by direct sales of software licenses, ongoing service contracts, and partner resales, with a focus on the Australian, New Zealand, and UK healthcare sectors. Alcidion’s business model emphasizes software licensing and service delivery, with Miya Precision as the primary revenue generator. The company’s strategic partnerships enable it to resell third-party software, expanding its product range without additional development costs. Healthcare institutions in Australia, New Zealand, and the United Kingdom are the primary buyers, leveraging Alcidion’s solutions for improved clinical workflows and operational efficiency. Alcidion Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alcidion Group stock

Long-Term Debt of Alcidion Group is 694,000.00 AUD in 2025.

Long-Term Debt of Alcidion Group changed from 998,000.00 AUD to 694,000.00 AUD, representing a -30.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt Alcidion Group since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Alcidion Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Alcidion Group

All Key Metrics — Alcidion Group